Blood lactate levels in patients receiving first- or second- generation antipsychotics
2011

Blood Lactate Levels in Patients on Antipsychotics

Sample size: 60 publication 10 minutes Evidence: moderate

Author Information

Author(s): Trpimir Glavina, Damir Mrass, Tajana Dodig, Gordana Glavina, Shelly Pranić, Boran Uglešić

Primary Institution: Split Clinical Hospital Center

Hypothesis

A 6-month treatment with haloperidol or olanzapine would change blood lactate levels and cause extrapyramidal side effects in patients without prior antipsychotic treatment.

Conclusion

Haloperidol treatment increases blood lactate levels and the risk of extrapyramidal side effects compared to olanzapine.

Supporting Evidence

  • Patients receiving haloperidol had significantly higher blood lactate levels than those receiving olanzapine.
  • Haloperidol treatment was associated with a higher incidence of parkinsonism and other extrapyramidal side effects.
  • Significant correlations were found between blood lactate levels and extrapyramidal symptoms in patients treated with haloperidol.

Takeaway

This study found that patients taking haloperidol had higher blood lactate levels and more side effects than those taking olanzapine.

Methodology

The study compared blood lactate levels in 60 patients with psychotic disorders treated with either haloperidol or olanzapine over 6 months.

Potential Biases

The non-randomized design may introduce bias in treatment assignment.

Limitations

The study was non-randomized and lacked a true control group, which may affect the validity of the comparisons.

Participant Demographics

Men aged 20-50 years with psychotic disorders.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.3325/cmj.2011.52.41

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication